Kangdong Liu Selected Research

purpurogallin

1/2019

Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kangdong Liu Research Topics

Disease

88	Neoplasms (Cancer) 05/2022 - 06/2009
33	Esophageal Squamous Cell Carcinoma 01/2022 - 12/2012
21	Carcinogenesis 01/2022 - 06/2009
15	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 12/2012
10	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2015
9	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 02/2015
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2018
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 10/2014
6	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2016
6	Inflammation (Inflammations) 11/2021 - 09/2016
5	Infections 01/2022 - 02/2008
5	Skin Neoplasms (Skin Cancer) 01/2021 - 02/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2012
4	Melanoma (Melanoma, Malignant) 01/2021 - 05/2011
4	Colonic Neoplasms (Colon Cancer) 10/2020 - 06/2011
4	Carcinoma (Carcinomatosis) 11/2018 - 12/2014
4	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2011
3	Mouth Neoplasms (Oral Cancer) 07/2021 - 04/2016
2	Esophagitis 01/2022 - 01/2017
2	Bone Resorption 01/2021 - 12/2016
2	Genomic Instability 01/2021 - 01/2021
2	COVID-19 01/2020 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2009
2	Triple Negative Breast Neoplasms 09/2019 - 06/2017
2	Neoplastic Cell Transformation 12/2018 - 01/2011
2	Squamous Cell Carcinoma of Head and Neck 05/2018 - 04/2016

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2009
13	Pharmaceutical PreparationsIBA 12/2021 - 06/2011
11	Phosphotransferases (Kinase)IBA 11/2021 - 11/2009
7	FlavonoidsIBA 01/2021 - 09/2013
7	Gefitinib (Iressa)FDA Link 01/2021 - 10/2014
6	CateninsIBA 01/2022 - 05/2017
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2015
5	AntioxidantsIBA 01/2021 - 04/2016
4	Aurora Kinase AIBA 01/2022 - 03/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2012
4	EnzymesIBA 01/2021 - 07/2015
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 11/2011
4	aloe emodinIBA 12/2018 - 07/2012
3	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2019
3	CarcinogensIBA 01/2022 - 11/2009
3	CytokinesIBA 01/2022 - 01/2020
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2020
3	AntigensIBA 08/2021 - 06/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 05/2018
3	Therapeutic UsesIBA 04/2021 - 05/2016
3	Protein Kinases (Protein Kinase)IBA 01/2021 - 06/2011
3	p21-Activated KinasesIBA 01/2021 - 01/2020
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 09/2013
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2020 - 07/2015
3	Small Interfering RNA (siRNA)IBA 02/2018 - 06/2009
2	Biological ProductsIBA 02/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 05/2018
2	Eflornithine (Ornidyl)FDA Link 01/2022 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2021
2	ubenimexIBA 11/2021 - 06/2019
2	IntegrinsIBA 10/2021 - 10/2011
2	IsoflavonesIBA 01/2021 - 05/2017
2	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 10/2020 - 12/2019
2	Annexin A5IBA 01/2020 - 01/2020
2	xanthohumolIBA 01/2020 - 01/2019
2	CaspasesIBA 01/2020 - 05/2018
2	Antimalarials (Antimalarial Agents)IBA 01/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 09/2016
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020 - 11/2018
2	ProteomeIBA 11/2019 - 01/2019
2	NF-kappa B (NF-kB)IBA 09/2019 - 01/2019
2	polypeptide 3 90kDa ribosomal protein S6 kinaseIBA 09/2019 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 06/2011
2	VaccinesIBA 11/2018 - 10/2016
2	eupatilinIBA 06/2018 - 09/2016
2	oridoninIBA 05/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 02/2018 - 12/2015
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018 - 05/2011
2	Estrogen ReceptorsIBA 06/2017 - 01/2017
2	theasinensin AIBA 06/2017 - 12/2012
2	Histone Deacetylase InhibitorsIBA 06/2017 - 06/2015
2	trichostatin A (A 300)IBA 06/2017 - 12/2012
2	ProstaglandinsIBA 01/2017 - 02/2015
2	PolyaminesIBA 01/2017 - 07/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015 - 07/2012
2	TensinsIBA 09/2015 - 07/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015 - 07/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015 - 02/2015
2	chrysinIBA 01/2014 - 09/2013
1	ginsenoside Rh2IBA 05/2022
1	HippocalcinIBA 02/2022
1	CalciumIBA 02/2022
1	AnthracyclinesIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022

Therapy/Procedure

16	Therapeutics 12/2021 - 06/2009
10	Chemoprevention 01/2022 - 02/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
3	Oral Administration 11/2021 - 09/2018
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Immunotherapy 01/2021 - 01/2019